Home NewLink Genetics

NewLink Genetics

In operation
IPO
Cancer Drug Developer
Basic
Enterprise Profile

Basic Information

NewLink Genetics is a biopharmaceutical company developing therapies and diagnostic tools for cancer and infectious disease patients. NewLink Genetics is at the forefront of the immuno-oncology treatment field, led by industry professionals from diverse backgrounds, including physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to transform the paradigm of cancer care and change patients' lives every day.
BioProtection Systems Corp.
Iowa,United States of America
51~100 people
January 01, 1999
info@newlinkgenetics.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs